The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the
“Company”), a Canadian Licensed Producer and global leader in
premium cannabis R&D, innovation, and cultivation, today
announced that it will release its fourth quarter 2018 results
after the close of the financial markets on Thursday, April 4,
2019.The Company will also host a conference call and webcast to
review these results. A question-and-answer session will
follow.Fourth Quarter 2018 Conference Call and Webcast:Thursday,
April 4, 20195:00 p.m. Eastern TimeToll Free:
1-877-705-6003Toll/International: 1-201-493-6725Webcast:
www.flowr.ca/investorsA telephonic replay of the call will be
available later that same day through Thursday, April 18, 2019. To
listen to the archived call, dial Toll Free 1-844-512-2921 or
Toll/International 1-412-317-6671 and enter replay pin number
13689126, or access the webcast replay via Flowr’s
website.Separately, Flowr also announced that it has engaged
Proactive Investors (www.proactiveinvestors.com), a leading
multi-media news organization, investor portal and events
management business with offices in New York, Sydney, Toronto,
Frankfurt and London. The group operates “investor forums” where
three or four companies present to an audience of high net worth
sophisticated investors, fund managers, hedge funds, private client
brokers and analysts.Flowr has engaged Proactive Investors for one
year beginning April 1, 2019 with an agreed upon annual retainer
fee of US$25,000. Neither Proactive Investors nor any of its
principals have an ownership interest, directly or indirectly, in
Flowr or its securities, and the Company has not granted Proactive
Investors or its principals any right to acquire such interests.The
Flowr CorporationFlowr, through its subsidiaries, holds a cannabis
production and sales license granted by Health Canada. With a
head office in Toronto and a production facility in Kelowna, BC,
Flowr builds and operates large-scale, GMP-designed cultivation
facilities utilizing its own patented growing systems. Flowr's
investment in research and development along with its sense of
craftsmanship and a spirit of innovation is expected to enable it
to provide premium-quality cannabis that appeals to the adult-use
recreational market and addresses specific patient needs in the
medicinal market.
For more information, visit www.flowr.ca. Follow Flowr on
Twitter: @FlowrCanada; Facebook: Flowr Canada; Instagram:
@flowrcanada; and LinkedIn: The Flowr Corporation.On behalf of The
Flowr Corporation:Tom FlowCo-CEO and Director
Forward-Looking Information
This press release includes forward-looking information within
the meaning of Canadian securities laws regarding Flowr and its
business, which may include, but are not limited to: statements
with respect to the release date of Flowr's financial
results, Flowr’s investment in research and development along
with its sense of craftsmanship and a spirit of innovation enabling
it to provide premium-quality cannabis that appeals to the
adult-use recreational market and address specific patient needs in
the medicinal market and other factors. Often, but not
always, forward-looking information can be identified by the use of
words such as “plans”, “is expected”, “expects”, “scheduled”,
“intends”, “contemplates”, “anticipates”, “believes”, “proposes” or
variations (including negative and grammatical variations) of such
words and phrases, or state that certain actions, events or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Such statements are based on the current expectations of
Flowr’s management and are based on assumptions and subject to
risks and uncertainties. Although Flowr’s management believes that
the assumptions underlying these statements are reasonable, they
may prove to be incorrect. The forward-looking events and
circumstances discussed in this press release may not occur by
certain specified dates or at all and could differ materially as a
result of known and unknown risk factors and uncertainties
affecting Flowr, including risks associated with a delay in
releasing Flowr’s financial statements (which could result in a
violation of applicable laws), Flowr not being able to
sustain its competitive advantage in cultivation and being unable
to remain at the forefront of industry innovation, whether as a
result of failed construction of the facilities or otherwise, Flowr
not being able to meet demand or fulfill purchase orders, which
could materially impact revenues and its relationships with
purchasers, Flowr requiring additional financing from time to time
in order to continue its operations and such financing may not be
available when needed or on terms and conditions acceptable to the
Company, new laws or regulations adversely affecting the Company’s
business and results of operations, results of operation activities
and development of projects, project cost overruns or unanticipated
costs and expenses, the inability of Flowr’s products to be high
quality, the inability of Flowr’s products to appeal to the
adult-use recreational market and address specific patient needs in
the medicinal market, the inability of Flowr to produce and
distribute premium, high quality products, the inability to supply
products or any delay in such supply, Flowr’s securities, the
inability to generate cash flows, revenues and/or stable margins,
the inability to grow organically, risks associated with the
geographic markets in which Flowr operates and/or distributes its
products, risks associated with fluctuations in exchange rates
(including, without limitation, fluctuations in currencies), risks
associated with the use of Flowr’s products to treat certain
conditions, the cannabis industry and the regulation thereof, the
failure to comply with applicable laws, risks relating to
partnership arrangements, possible failure to realize the
anticipated benefits of partnership arrangements, product launches
(including, without limitation, unsuccessful product launches), the
inability to launch products, the failure to obtain regulatory
approvals, economic factors, market conditions, risks associated
with the acquisition and/or launch of products, the equity and debt
markets generally, risks associated with growth and competition
(including, without limitation, with respect to Flowr’s products),
general economic and stock market conditions, risks and
uncertainties detailed from time to time in Flowr’s filings with
the Canadian Securities Administrators and many other factors
beyond the control of Flowr. Although Flowr has attempted to
identify important factors that could cause actual actions, events
or results to differ materially from those described in
forward-looking information, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. No forward-looking information can be
guaranteed. Except as required by applicable securities laws,
forward-looking information speaks only as of the date on which it
is made and Flowr undertakes no obligation to publicly update or
revise any forward-looking information, whether as a result of new
information, future events, or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this press release.CONTACT INFORMATION: U.S. MEDIA:Tim
Streeb, ICR1-646-677-1800Tim.Streeb@icrinc.com
CANADIAN MEDIA:Rebecca Brown, Crowns
Agency1-647-456-5599rebecca@crowns.agency
IR:Raphael Gross, ICR1-203-682-8253Raphael.Gross@icrinc.comFOR
INVESTORS ONLY:Bram JuddThe Flowr Corporation+1-647-483-7065 ext.
1520bram@flowr.ca
Jim Walsh
The Flowr Corporation
+1-607-275-7141
jwalsh@flowr.ca
The Flowr (TSXV:FLWR)
Historical Stock Chart
From Mar 2024 to Apr 2024
The Flowr (TSXV:FLWR)
Historical Stock Chart
From Apr 2023 to Apr 2024